BVT Knock-Out PGR/ DE000VD1LL48 /
| 5/13/2024 4:43:46 PM | Chg.+0.220 | Bid5:27:13 PM | Ask5:27:13 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 2.180EUR | +11.22% | 2.110 Bid Size: 16,000 |
2.130 Ask Size: 16,000 |
Progressive Corporat... | 235.65 - | 12/31/2078 | Put |
GlobeNewswire
4:01 PM
Pythian’s Vanessa Simmons and Donna Williston Honored by CRN on 2024 Women of the Channel Lists
GlobeNewswire
3:33 PM
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Se...
GlobeNewswire
3:33 PM
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial...
GlobeNewswire
2:35 PM
DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Subsidiary’s AUM of C$748M, a 47.2%...
GlobeNewswire
2:15 PM
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
2:00 PM
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:00 PM
Avalyn Announces Multiple Presentations on its Lead Program, AP01, for Pulmonary Fibrosis and its Ap...
GlobeNewswire
1:30 PM
BridgeBio Pharma Presents Additional Data and Analyses from its Phase 3 ATTRibute-CM Study in Transt...
GlobeNewswire
1:00 PM
Tiziana Life Sciences Files for Orphan Drug Designation for Intranasal Foralumab
GlobeNewswire
1:00 PM
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 20...
GlobeNewswire
12:00 PM
Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Developme...
GlobeNewswire
8:30 AM
Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase...
GlobeNewswire
5/9
Travere Therapeutics to Present at National Kidney Foundation Spring Clinical Meetings and the 61st ...
GlobeNewswire
5/9
Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate...
GlobeNewswire
5/8
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Plan...
GlobeNewswire
5/7
MediciNova Receives Issue Notification for New Patent Covering Extended-Release Formulations of MN-1...
GlobeNewswire
5/6
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at th...
GlobeNewswire
5/4
The National Fire Sprinkler Association's Class of 2024: Honoring Fire Sprinkler Industry Greats
GlobeNewswire
5/2
PyroGenesis Announces 28-Day Lab Strength Tests Achieve Up to 99.56% Above Compressive Strength Targ...
GlobeNewswire
5/1
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
5/1
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 ...
